Mode
Text Size
Log in / Sign up
Phase 2 Completed N=332 Randomized Treatment

Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use

Source: ClinicalTrials.gov NCT00218296 ↗
Enrolled (actual)
332
Serious AEs
0.0%
Results posted
Dec 2013
Primary outcomePrimary: Percent Abstinent From Tobacco at Week 12 (7 Day Point Prevalence) — 31; 17 percentage of randomized — p=0.04

Summary

Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has health risks associated with its use. While treatment programs that focus on stopping tobacco use may be effective, past research has shown that interventions that specifically focus on reducing tobacco use may be equally effective and may motivate individuals to eventually quit using tobacco. This study will compare the effectiveness of a ST reduction treatment program versus a usual tobacco cessation treatment program (immediate cessation) for reducing tobacco use in ST users.

Outcome Measures

OutcomeResultp-value
PRIMARY
Percent Abstinent From Tobacco at Week 12 (7 Day Point Prevalence)
31; 17 0.04 sig
PRIMARY
Percent Prolonged Abstinence From Tobacco at Week 12
13; 4 0.019 sig
PRIMARY
Percent Abstinent From Tobacco at Week 26 (7 Day Point Prevalence)
20; 10 0.03 sig
PRIMARY
Percent Prolonged Abstinence From Tobacco at Week 26
11; 1 .002 sig
PRIMARY
Percent Abstinent From Tobacco at Week 32 (7 Day Point Prevalence)
20; 11 0.056
PRIMARY
Percent Prolonged Abstinence From Tobacco at Week 32
11; 1 0.002 sig

Eligibility Criteria

Inclusion Criteria

  • No interest in stopping ST use within 90 days of study entry
  • Daily use of ST in the 6 months prior to study entry

Exclusion Criteria

  • Current use of tobacco or nicotine products, other than ST
  • Current unstable medical and mental health conditions
  • Use of any medication that may affect tobacco use or be affected by a reduction in tobacco use
  • Pregnant or breastfeeding
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00218296). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search